| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.23 | 9e-05 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.26 | 0.002 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |